Author

Mayu Obora

Tottori University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Assay:fluorescence / live-cell microscopy· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Daisuke NanbaiD· 1 shared Hiroyuki TsuchiyaiD· 1 shared Jun YoshidaiD· 1 shared Mikiya Kishino· 1 shared Takehiko HanakiiD· 1 shared Yoshiyuki Fujiwara· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Daisuke NanbaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

High-throughput heterospheroid-based screening identifies drugs that reprogram tumor-associated macrophages

Hiroyuki Tsuchiya, Takehiko Hanaki, Mayu Obora, Jun Yoshida, Mikiya Kishino, Yoshiyuki Fujiwara, Daisuke Nanba

This study identifies two compounds that reprogram tumor-associated macrophages from M2-like to M1-like antitumor phenotype using a heterospheroid-based screening platform.

Journal of Immunology Research · Jan 1, 2026Peer-reviewedPharmacology & Toxicology